Virax Biolabs to Present at 19th World Immune Regulation Meeting

Core Insights - Virax Biolabs Group Limited will present at the 19th World Immune Regulation Meeting (WIRM) in Davos, Switzerland from March 12-15, 2025 [1] - The presentation will focus on T cell dysfunction in post-acute infection syndromes, led by Dr. Nigel McCracken, the Chief Operating Officer [2] - The company will showcase its immune profiling products for research use at Booth 116 during the conference [2] Company Overview - Virax Biolabs is a biotechnology company specializing in the detection of immune responses and diagnosis of viral diseases [4] - The company is developing T-Cell-based test technologies aimed at providing an immunology profiling platform, particularly for diagnosing post-viral syndromes like Long COVID [4] Event Details - WIRM 2025 will host around 600 scientists and clinicians globally, featuring scientific lectures, networking opportunities, and a poster exhibition [3]